You might want to have a conversation about that. Abasaglar is Glargine and is proven to be more variable and increase severe hypo risk versus both Levemir and Tresiba. In your position I would be saying no to that. If you want some links I can provide them to you.My doctor has changed all my prescriptions to cheaper alternatives, like levemir to abasaglar
You might want to have a conversation about that. Abasaglar is Glargine and is proven to be more variable and increase severe hypo risk versus both Levemir and Tresiba. In your position I would be saying no to that. If you want some links I can provide them to you.
I also think you should change GP with the attitude yours seems to have.
I think this is very good.she also moved me from the care of GP surgery to the care of the Diabetic centre on hospital, so at least I will be seeing a Endo Doctor
I think this is very good.
If there is a problem with the insulin (or test strips) your GP has prescribed, you should have the support on the endo doctor to overturn this. The Endo should know how to manage diabetes much much better than a General Practitioner.
Hopefully, you get an appointment with the Endo soon.
You might want to have a conversation about that. Abasaglar is Glargine and is proven to be more variable and increase severe hypo risk versus both Levemir and Tresiba. In your position I would be saying no to that. If you want some links I can provide them to you.
I also think you should change GP with the attitude yours seems to have.
Hi, i expect you are in London, the situation there is not yet so fraught, most of the changes are coming in to other areas, i have been told that the doctors here no longer have the final say on prescribing, it is the pharmacist, who works with the CCG and one who works with the practice and/or the CCG, stuff can just go from your prescription, type 2s are faring the worst here, and type ones who are not in hospital, but soon whatever hospital letters you have will be redundant unless renewned within the last year - this is going to drive hospitals mad, i imagine, and in this area, from a council meeting, i can see that soon hospitals will have to speed discharges back to GP, all areas were being talked about. in some depts there is such a rush to discharge that there is not even one follow up to see how the patient is managing.
Good point well made. Probably a rhetorical question, but is the same person responsible for both budgets?Hi @ann34+, whilst that may be the case, we're facing the same CCG idiocy about not understanding the health economics here. Every time that someone using Glargine ends up in hospital or calling out an ambulance, the cost of the cheaper insulin is overridden multiple times by the cost of simply an ambulance call out.
As an example:
An annual supply of Glargine for a type 1 using 30u a day (a not unreasonable average) costs £113.31. The tresiba equivalent is £139.8. (I'm using Tresiba because I don't have the data for increased hypos of Lantus compared to Levemir, but do for Tresiba).
Tresiba is therefore 23% more expensive.
However, as the SWITCH1 trial showed, when you are using Lantus you are one third more likely to have a severe hypo that will need an ambulance call out and may result in hospitalisation than Tresiba.
In real terms that's one severe hypo annually. Or in other words, it costs an additional £240 per year to call an ambulance to deal with that hypo.
On the Tresiba, it's likely to happen once every 18 months, or in other words, it costs £160 per year.
The cost saving of using Lantus over Tresiba at a prescription level is £26.49 per year, so the increased ambulance call out cost (£240 vs £160) means that Lantus really costs at least £53.51 per year more than Tresiba. And that excludes any hospitalisation as a result of the ambulance call out.
My point? It's worth delving into the health economics of any decision that a CCG makes and digging through the data, as it's very easy to make it clear to them that their policy not only costs more, but is demonstrably negligent in its outcomes, and CCGs don't like either of those things.
Feel free to use this analysis with your healthcare team to make your point.
Hi @ann34+, whilst that may be the case, we're facing the same CCG idiocy about not understanding the health economics here. Every time that someone using Glargine ends up in hospital or calling out an ambulance, the cost of the cheaper insulin is overridden multiple times by the cost of simply an ambulance call out.
As an example:
An annual supply of Glargine for a type 1 using 30u a day (a not unreasonable average) costs £113.31. The tresiba equivalent is £139.8. (I'm using Tresiba because I don't have the data for increased hypos of Lantus compared to Levemir, but do for Tresiba).
Tresiba is therefore 23% more expensive.
However, as the SWITCH1 trial showed, when you are using Lantus you are one third more likely to have a severe hypo that will need an ambulance call out and may result in hospitalisation than Tresiba.
In real terms that's one severe hypo annually. Or in other words, it costs an additional £240 per year to call an ambulance to deal with that hypo.
On the Tresiba, it's likely to happen once every 18 months, or in other words, it costs £160 per year.
The cost saving of using Lantus over Tresiba at a prescription level is £26.49 per year, so the increased ambulance call out cost (£240 vs £160) means that Lantus really costs at least £53.51 per year more than Tresiba. And that excludes any hospitalisation as a result of the ambulance call out.
My point? It's worth delving into the health economics of any decision that a CCG makes and digging through the data, as it's very easy to make it clear to them that their policy not only costs more, but is demonstrably negligent in its outcomes, and CCGs don't like either of those things.
Feel free to use this analysis with your healthcare team to make your point.
I used to barely test to be honest. It was bad of me but I wasn't off the rails or whatever, just used to sit around 7-9 all day every day so just stopped checking it as I could always feel when I hypo'ed anyway. Now, I test frequently 6 times a day roughly. . Had a little scare I guess a few days ago where I was in the 2s on consecutive days and didn't even feel it both times though and that accompanied by the fact I have about 5 or 6 hypo's a week these days has made me test even more the last couple days. I tested 15 times yesterday for god sake out of worry that I'm going to hypo and not feel it. Could worry that the doctors will moan at me for the rate I'm going through these testing strips but screw it, It's my health, and I don't care if I'm costing them a little bit of money going through a box of 50 a week, I saved them money when I used to only go through a box a month when I wasn't testing very frequently.
I have just been diagnosed with Type 1. I am testing at least 10 times a day in order to understand my condition and my body. I am negotiating with my local NHS trust about the cost v benefit of the Freestyle Libre v strips. I must say the NHS have been amazing over the last couple of weeks from my original ketone problem, my 111 HbA1c and now 7.8 average in my 2nd week. without regular testing this would not have been possible. As its an auto immune problem and not lifestyle caused I believe we all deserve as many strips as we believe necessary to manage the condition or access to at least a trial of the Freestyle Libre system.
I am in Scotland and the pharmacist I go was asking do I need blood strips so often,I said it depends on my blood sugar levels. Pharmacy even asked if one lantus pen could do me a month
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?